| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.0069 | 1 |